Albatroz Therapeutics Soars into Johnson & Johnson Innovation - JLABS Singapore

2024-09-04 Albatroz Therapeutics Pte Ltd HaiPress

SINGAPORE,Sept. 3,2024 -- Albatroz Therapeutics,a biotechnology company developing novel therapies against cancer and other indications,today announced its membership of Johnson & Johnson Innovation – JLABS Singapore.

"We are thrilled to join the vibrant life science community at JLABS," said Dr. Frederic Bard,CEO of Albatroz Therapeutics. "This membership provides Albatroz with invaluable access to mentorship,infrastructure,and industry connections that will be instrumental in propelling our groundbreaking therapies towards the clinic."

Revolutionizing Cancer Treatment

Albatroz Therapeutics is at the forefront of developing targeted therapies that address critical unmet needs in oncology. The company's lead programs focus on disrupting key pathways that result in tumor growth and metastasis. By joining JLABS Singapore,Albatroz gains access to a supportive ecosystem that will expedite the translation of its scientific discoveries into life-saving treatments for patients worldwide.

Looking Ahead

"We are confident that our membership with JLABS Singapore will significantly contribute to the success of Albatroz Therapeutics," Dr. Bard concluded. "We are committed to working diligently to bring our novel therapies to fruition and transform the landscape of cancer treatment."

About Albatroz Therapeutics

Albatroz Therapeutics is a pre-clinical stage biotechnology company dedicated to developing innovative treatments for cancer,arthritis and other diseases where tissue remodeling is prevalent. The company leverages its deep scientific expertise to identify and target critical pathways involved in the degradation of tissues. Albatroz is committed to translating cutting-edge research into effective therapies that improve the lives of patients.

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

1Breaking Boundaries, Investing Without Limits: CNC Aggregated Trading Platform Leading the New Era of Globalized Investments

Breaking Boundaries, Investing Without Limits: CNC Aggregated Trading Platform Leading the New Era of Globalized Investments

2Se celebra la 68ª sesión de la Comisión de Estupefacientes de las Naciones Unidas: China, un participante activo en la lucha global contra las drogas

Se celebra la 68ª sesión de la Comisión de Estupefacientes de las Naciones Unidas: China, un participante activo en la lucha global contra las drogas

3AXES TREE LLC Launches AXES USDT: Blockchain Meets Advertising

AXES TREE LLC Launches AXES USDT: Blockchain Meets Advertising

4Laika Officially Launches the MMS Token Swap Program: Premium Members Unite to Drive a New Market Era

Laika Officially Launches the MMS Token Swap Program: Premium Members Unite to Drive a New Market Era

5"Daily Get·Lottery fund trust services (formerly Cola Financial) and มิราเคิล กรุ๊ป จำกัด reached a strategic cooperation in lottery fund trust to jointly usher in a new era of sunshine in the Asia-Pacific lottery market"

"Daily Get·Lottery fund trust services (formerly Cola Financial) and มิราเคิล กรุ๊ป จำกัด reached a strategic cooperation in lottery fund trust to jointly usher in a new era of sunshine in the Asia-Pacific lottery market"

6Congratulations on Hannah Yihan Liu's works participating in the LUV International Art Exhibition!

Congratulations on Hannah Yihan Liu's works participating in the LUV International Art Exhibition!

©copyright 2009-2020 Diet Tips Daily